2,738
Views
19
CrossRef citations to date
0
Altmetric
Research Paper

Barriers to COVID-19 vaccination among medical students in Kazakhstan: development, validation, and use of a new COVID-19 Vaccine Hesitancy Scale

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 4982-4992 | Received 14 May 2021, Accepted 13 Sep 2021, Published online: 06 Oct 2021

References

  • Li YD, Chi WY, Su JH, Ferrall L, Hung CF, Wu TC. Coronavirus vaccine development: from SARS and MERS to COVID-19. J Biomed Sci. 2020 Dec 1;27. BioMed Central Ltd. doi:10.1186/s12929-020-00695-2.
  • Excler JL, Saville M, Berkley S, Kim JH. Vaccine development for emerging infectious diseases. Nat Med. 2021 Apr 1;27:591–600. Nature Research. doi:10.1038/s41591-021-01301-0.
  • Zakarya K, Kutumbetov L, Orynbayev M, Abduraimov Y, Sultankulova K, Kassenov M, Sarsenbayeva, G, Kulmagambetov, I, Davlyatshin, T, Sergeeva, M, et al. Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: a single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan. EClinicalMedicine. 2021:101078. doi:10.1016/j.eclinm.2021.101078.
  • What you should know about the COVID-19 Vaccine. 2021. www.Coronavirus2020.Kz. https://www.coronavirus2020.kz/ru/vaccine.
  • Zhunusova A. Coronavirus vaccination began in Kazakhstan: what you need to know. Tengrinews.Kz. 2021 Feb 1. https://tengrinews.kz/kazakhstan_news/vaktsinatsiya-koronavirusa-nachalas-kazahstane-nujno-znat-427018/.
  • Smayil, M. Vaccination failure in Kazakhstan. Why Tokayev had to intervene. 2021 Apr 1. www.Tengrinews.Kz. https://tengrinews.kz/kazakhstan_news/proval-vaktsinatsii-kazahstane-pochemu-tokaevu-prishlos-433326/.
  • Larson HJ, Jarrett C, Schulz WS, Chaudhuri M, Zhou Y, Dube E, Hickler B, MacDonald NE, Wilson R. Measuring vaccine hesitancy: the development of a survey tool. Vaccine. 2015;33(34):4165–75. doi:10.1016/j.vaccine.2015.04.037.
  • Sallam M, Dababseh D, Eid H, Al-Mahzoum K, Al-Haidar A, Taim D, Yaseen A, Ababneh NA, Bakri FG, Mahafzah A. High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: a study in Jordan and Kuwait among other Arab countries. Vaccines. 2021;9(1):42. doi:10.3390/vaccines9010042.
  • Freeman D, Loe B, Chadwick A, Vaccari C, Waite F, Rosebrock L, Jenner, L, Petit, A, Lewandowsky, S, Vanderslott, S, et al. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol Med. 2020:1–15. doi:10.1017/S0033291720005188.
  • Fisk RJ. Barriers to vaccination for coronavirus disease 2019 (COVID-19) control: experience from the United States. Glob Health J. 2021;5(1):51–55. doi:10.1016/j.glohj.2021.02.005.
  • Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: implications for public health communications. Lancet Regional Health - Europe. 2021;1:100012. doi:10.1016/j.lanepe.2020.100012.
  • Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, Wong LP. Understanding COVID-19 vaccine demand and hesitancy: a nationwide online survey in China. PLoS Negl Trop Dis. 2020;14(12):e0008961. doi:10.1371/journal.pntd.0008961.
  • Murphy J, Vallières F, Bentall RP, Shevlin M, McBride O, Hartman TK, Hyland P, Bennett K, Mason L, Gibson-Miller J. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat Commun. 2021;12:1. doi:10.1038/s41467-020-20226-9.
  • Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy: an overview. Hum Vaccin Immunother. 2013;9(8):1763–73. doi:10.4161/hv.24657.
  • Kreps S, Prasad S, Brownstein JS, Hswen Y, Garibaldi BT, Zhang B, Kriner DL. Factors associated with US adults’ likelihood of accepting COVID-19 vaccination. JAMA Netw Open. 2020;3(10):e2025594. doi:10.1001/jamanetworkopen.2020.25594.
  • Shapiro GK, Tatar O, Dube E, Amsel R, Knauper B, Naz A, Perez S, Rosberger Z. The Vaccine Hesitancy Scale: psychometric properties and validation. Vaccine. 2018;36(5):660–67. doi:10.1016/j.vaccine.2017.12.043.
  • Akhmetzhanova Z, Sazonov V, Riethmacher D, Aljofan M. Vaccine adherence: the rate of hesitancy toward childhood immunization in Kazakhstan. Expert Rev Vaccines. 2020;19(6):579–84. doi:10.1080/14760584.2020.1775080.
  • Harrison EA, Wu JW. Vaccine confidence in the time of COVID-19. Eur J Epidemiol. 2020;35:325–30. doi:10.1007/s10654-020-00634-3.
  • Wallace AS, Wannemuehler K, Bonsu G, Wardle M, Nyaku M, Amponsah-Achiano K, Dadzie JF, Sarpong FO, Orenstein WA, Rosenberg ES, et al. Development of a valid and reliable scale to assess parents’ beliefs and attitudes about childhood vaccines and their association with vaccination uptake and delay in Ghana. Vaccine. 2019;37(6):848–56. doi:10.1016/j.vaccine.2018.12.055.
  • DeVellis RF. Scale development: theory and applications. 2nd ed. Thousand Oaks (CA): SAGE Publications, Inc; 2003.
  • Xia Y, Yang Y. RMSEA, CFI, and TLI in structural equation modeling with ordered categorical data: the story they tell depends on the estimation methods. Behav Res Methods. 2019;51(1):409–28. doi:10.3758/s13428-018-1055-2.
  • Taber KS. The use of Cronbach’s alpha when developing and reporting research instruments in science education. Res Sci Educ. 2018;48(6):1273–96. doi:10.1007/s11165-016-9602-2.
  • Habibzadeh F, Habibzadeh P, Yadollahie M. On determining the most appropriate test cut-off value: the case of tests with continuous results. Biochem Med. 2016;26(3):297–307. doi:10.11613/BM.2016.034.
  • Szmyd B, Bartoszek A, Karuga FF, Staniecka K, Błaszczyk M, Radek M. Medical students and SARS-CoV-2 vaccination: attitude and behaviors. Vaccines. 2021;9(2):128. doi:10.3390/vaccines9020128.
  • Sallam M. COVID-19 vaccine hesitancy worldwide: a systematic review of vaccine acceptance rates. Vaccines. 2020:2020120717. Preprints. doi:10.20944/preprints202012.0717.v1.
  • Ray BJ. Over 1 billion worldwide unwilling to take COVID-19 vaccine. Gallup.Com. 2021 May 7. https://news.gallup.com/poll/348719/billion-unwilling-covid-vaccine.aspx.
  • Issanov A, Akhmetzhanova Z, Riethmacher D, Aljofan M. Knowledge, attitude, and practice toward COVID-19 vaccination in Kazakhstan: a cross-sectional study. Hum Vaccin Immunother. 2021:1–7. doi:10.1080/21645515.2021.1925054.
  • Soares P, Rocha JV, Moniz M, Gama A, Laires PA, Pedro AR, Dias S, Leite A, Nunes C. Factors associated with COVID-19 vaccine hesitancy. Vaccines. 2021;9(3):300. doi:10.3390/vaccines9030300.
  • Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021;397(10275):671–81. doi:10.1016/S0140-6736(21)00234-8.
  • Krivtsanova K. Kazakhstan’s vaccine is effective against new mutations COVID-19, said the head of the research institute. NUR.KZ. 2021, Apr 2. https://www.nur.kz/society/1905982-kazahstanskaya-vaktsina-effektivna-protiv-novyh-mutatsiy-covid-19-zayavila-glava-nii/.
  • Grochowska M, Ratajczak A, Zdunek G, Adamiec A, Waszkiewicz P, Feleszko W. A comparison of the level of acceptance and hesitancy towards the influenza vaccine and the forthcoming COVID-19 vaccine in the medical community. Vaccines. 2021;9(5):475. doi:10.3390/vaccines9050475.
  • Rabi R, Maraqa B, Nazzal Z, Zink T. Factors affecting nurses’ intention to accept the COVID‐9 vaccine: a cross‐sectional study. Public Health Nurs. 2021;38:781–88. doi:10.1111/phn.12907.
  • Urrunaga-Pastor D, Bendezu-Quispe G, Herrera-Añazco P, Uyen-Cateriano A, Toro-Huamanchumo CJ, Rodriguez-Morales AJ, Hernandez, AV, Benites-Zapata VA. Cross-sectional analysis of vaccine intention, perceptions and hesitancy across Latin America and the Caribbean. Travel Med Infect Dis. 2021:102059. doi:10.1016/j.tmaid.2021.102059.
  • Zintel S, Flock C, Arbogast AL, Forster A, von Wagner C, Sieverding M. Gender differences in the intention to get vaccinated against COVID-19 - a systematic review and meta-analysis. SSRN. 2021 Mar 12. https://ssrn.com/abstract=3803323.
  • Khubchandani J, Sharma S, Price JH, Wiblishauser MJ, Sharma M, Webb FJ. COVID-19 vaccination hesitancy in the United States: a rapid national assessment. J Community Health. 2021;46(2):270–77. doi:10.1007/s10900-020-00958-x.
  • Tsai FJ, Yang HW, Lin CP, Liu JZ. Acceptability of covid-19 vaccines and protective behavior among adults in Taiwan: associations between risk perception and willingness to vaccinate against COVID-19. Int J Environ Res Public Health. 2021;18:11. doi:10.3390/ijerph18115579.
  • Adeniyi OV, Stead D, Singata-Madliki M, Batting J, Wright M, Jelliman E, Abrahams S, Parrish A. Acceptance of COVID-19 vaccine among the healthcare workers in the Eastern Cape, South Africa: a cross sectional study. Vaccines. 2021;9(6):666. doi:10.3390/vaccines9060666.
  • MacDonald NE, Eskola J, Liang X, Chaudhuri M, Dube E, Gellin B, Goldstein S, Larson H, Manzo M, Reingold A, et al. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–64. doi:10.1016/j.vaccine.2015.04.036.
  • Baghdadi LR, Alghaihb SG, Abuhaimed AA, Alkelabi DM, Alqahtani RS. Healthcare workers’ perspectives on the upcoming COVID-19 vaccine in terms of their exposure to the influenza vaccine in Riyadh, Saudi Arabia: a cross-sectional study. Vaccines. 2021;9(5):465. doi:10.3390/vaccines9050465.
  • Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health. 2021;6(4):e210–e221. doi:10.1016/S2468-2667(21)00012-8.
  • Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–28. doi:10.1038/s41591-020-1124-9.
  • Dror AA, Daoud A, Morozov NG, Layous E, Eisenbach N, Mizrachi M, Rayan D, Bader A, Francis S, Kaykov E. Vaccine hesitancy due to vaccine country of origin, vaccine technology, and certification. Eur J Epidemiol. 2021;36(7):709–14. doi:10.1007/s10654-021-00758-0.
  • Zarobkiewicz MK, Zimecka A, Zuzak T, Cieślak D, Roliński J, Grywalska E. Vaccination among Polish university students. Knowledge, beliefs and anti-vaccination attitudes. Hum Vaccin Immunother. 2017;13(11):2654–58. doi:10.1080/21645515.2017.1365994.
  • Kernéis S, Jacquet C, Bannay A, May T, Launay O, Verger P, Pulcini C, Abgueguen P, Ansart S, Bani-Sadr F; EDUVAC Study Group. Vaccine education of medical students: a nationwide cross-sectional survey. Am J Prev Med. 2017;53(3):e97–e104. doi:10.1016/j.amepre.2017.01.014.
  • Rostkowska OM, Peters A, Montvidas J, Magdas TM, Rensen L, Zgliczyński WS, Durlik M, Pelzer BW. Attitudes and knowledge of European medical students and early graduates about vaccination and self-reported vaccination coverage—multinational cross-sectional survey. Int J Environ Res Public Health. 2021;18(7):7. doi:10.3390/ijerph18073595.
  • Lucia VC, Kelekar A, Afonso NM. COVID-19 vaccine hesitancy among medical students. J Public Health (Oxford, England). 2020. fdaa230. Advance online publication. doi:10.1093/pubmed/fdaa230.
  • McKee M, Rajan S. What can we learn from Israel’s rapid roll out of COVID 19 vaccination? Isr J Health Policy Res. 2021 Dec 1. BioMed Central Ltd. doi:10.1186/s13584-021-00441-5.
  • Marchildon GP. The rollout of the COVID-19 vaccination: what can Canada learn from Israel?. Isr J Health Policy Res. 2021 Dec 1. BioMed Central Ltd. doi:10.1186/s13584-021-00449-x.
  • Rosen B, Waitzberg R, Israeli A. Israel’s rapid rollout of vaccinations for COVID-19. Isr J Health Policy Res. 2021;10:1. doi:10.1186/s13584-021-00440-6.
  • Talukdar D, Stojkovski K, Suarez D. Role of information technology in COVID19 vaccination drive: an analysis of the COVID-19 global beliefs, behaviors, and norms survey. 2021. p. 2021040552. Preprints. doi:10.20944/preprints202104.0552.v1.
  • Schoch-Spana M, Brunson EK, Long R, Ruth A, Ravi SJ, Trotochaud M, Borio L, Brewer J, Buccina J, Connell N, et al. The public’s role in COVID-19 vaccination: human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States. Vaccine. 2020:S0264-410X(20) 31368–2. Advance online publication. doi:10.1016/j.vaccine.2020.10.059.
  • Solís Arce JS, Warren SS, Meriggi NF, Scacco A, Mcmurry N, Voors M, Syunyaev G, Malik AA, Aboutajdine S, Adeojo O, et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021;27(8):1385–94. doi:10.1038/s41591-021-01454-y.
  • Tavolacci MP, Dechelotte P, Ladner J. COVID-19 vaccine acceptance, hesitancy, and resistancy among university students in France. Vaccines. 2021;9(6):654. doi:10.3390/vaccines9060654.
  • Saied SM, Saied EM, Kabbash IA, Abdo SAEF. Vaccine hesitancy: beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students. J Med Virol. 2021;93(7):4280–91. doi:10.1002/jmv.26910.
  • Akel KB, Masters NB, Shih SF, Lu Y, Wagner AL. Modification of a Vaccine Hesitancy Scale for use in adult vaccinations in the United States and China. Hum Vaccin Immunother. 2021. doi:10.1080/21645515.2021.1884476.
  • Freeman D, Loe BS, Chadwick A, Vaccari C, Waite F, Rosebrock L, Jenner, L., Petit, A., Lewandowsky, S., Vanderslott, S, et al. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol Med. 2021. doi:10.1017/S0033291720005188.
  • Rodriguez VJ, Alcaide ML, Salazar AS, Montgomerie EK, Maddalon MJ, Jones DL. Psychometric properties of a Vaccine Hesitancy Scale adapted for COVID-19 vaccination among people with HIV. AIDS Behav. 2021:1–6. Advance online publication. doi:10.1007/s10461-021-03350-5.
  • Biswas N, Mustapha T, Khubchandani J, Price JH. The nature and extent of COVID-19 vaccination hesitancy in healthcare workers. J Community Health. 2021. doi:10.1007/s10900-021-00984-3.
  • Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, Srouji S, Sela E. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020;35(8):775–79. doi:10.1007/s10654-020-00671-y.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.